Welcome to LookChem.com Sign In|Join Free

CAS

  • or

3337-17-5

Post Buying Request

3337-17-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

3337-17-5 Usage

Chemical structure

1,4-dihydropyridine is an organic compound with a heterocyclic ring structure consisting of a five-membered ring with four carbon atoms and one nitrogen atom.

Pharmacological properties

This chemical is known for its pharmacological properties, making it a valuable compound in the development of various drugs.

Building block in drug synthesis

1,4-dihydropyridine is often used as a building block in the synthesis of new drugs due to its versatile chemical structure.

Calcium channel blockers

One of the most well-known applications of 1,4-dihydropyridine is in the development of calcium channel blockers, which are used to treat conditions such as hypertension and angina.

Treatment of hypertension

Calcium channel blockers, which often contain 1,4-dihydropyridine, are commonly used to treat high blood pressure (hypertension).

Treatment of angina

These compounds are also used to treat angina, a type of chest pain caused by reduced blood flow to the heart.

Potential therapeutic effects

1,4-dihydropyridine has been investigated for its potential therapeutic effects in various other diseases and disorders, including neurodegenerative diseases and cancer.

Versatile chemical

1,4-dihydropyridine is a versatile chemical with important applications in both the pharmaceutical industry and research into new medical treatments.

Research into new treatments

The compound's potential applications in treating a range of diseases make it a valuable subject of research for the development of new medical treatments.

Pharmaceutical industry

1,4-dihydropyridine plays a significant role in the pharmaceutical industry, particularly in the development and production of calcium channel blockers and other drugs.

Check Digit Verification of cas no

The CAS Registry Mumber 3337-17-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,3,3 and 7 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 3337-17:
(6*3)+(5*3)+(4*3)+(3*7)+(2*1)+(1*7)=75
75 % 10 = 5
So 3337-17-5 is a valid CAS Registry Number.
InChI:InChI=1/C5H7N/c1-2-4-6-5-3-1/h2-6H,1H2

3337-17-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name [Bodipyl-FL]-1,4-Dihydropyridine

1.2 Other means of identification

Product number -
Other names 1,4-dihydropyridine diester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:3337-17-5 SDS

3337-17-5Relevant articles and documents

Fowler

, p. 1321 (1972)

Electrochemistry of aqueous pyridinium: Exploration of a key aspect of electrocatalytic reduction of CO2 to methanol

Yan, Yong,Zeitler, Elizabeth L.,Gu, Jing,Hu, Yuan,Bocarsly, Andrew B.

, p. 14020 - 14023 (2013)

The mechanism by which pyridinium (pyrH+) is reduced at a Pt electrode is a matter of recent controversy. The quasireversible cyclic voltammetric wave observed at -0.58 V vs SCE at a Pt electrode was originally proposed to correspond to reduction of pyrH+ to pyridinyl radical (pyrH?). This mechanistic explanation for the observed electrochemistry seems unlikely in light of recent quantum mechanical calculations that predict a very negative reduction potential (-1.37 V vs SCE) for the formation of pyrH?. Several other mechanisms have been proposed to account for the discrepancy in calculated and observed reduction potentials, including surface adsorption of pyrH?, reduction of pyrH+ by two electrons rather than one, and reduction of the pyrH+ proton to a surface hydride rather than a π-based radical product. This final mechanism, which can be described as inner-sphere reduction of pyrH+ to form a surface hydride, is consistent with experimental observations.

de Koning et al.

, p. 2547 (1977)

Chemo- and regioselective catalytic reduction of N-heterocycles by silane

Lee, Sun-Hwa,Gutsulyak, Dmitry V.,Nikonov, Georgii I.

supporting information, p. 4457 - 4464 (2013/09/23)

The ruthenium complex [Cp(iPr3P)Ru(NCCH3) 2]+ (1) catalyzes the regioselective hydrosilylation of pyridines to 1,4-dihydropyridines. Substitution in the 3- and 5-positions is tolerated, whereas pyridines with substituents in the 2-, 4-, and 6-positions are not reduced. Reduction of functionalized pyridines having keto and ester substituents results in a mixture of products. N-Silyl-1,4-dihydropyridine reacts with ketones and aldehydes to give products of N-Si addition across the C=O bond. Hydrosilylation of pyridine in acetone results quantitatively in the addition product PhMe2SiO-CMe2-NC5H 6, which decomposes in hexane to give the parent dihydropyridine HNC5H6. The phenanthroline complex [Cp(phen)Ru(NCCH 3)2]+ (10) catalyzes regioselective 1,4-reduction of phenanthroline by a 3-4-fold excess of silane/water or silane/alcohol mixtures. The Cp* analogue [Cp*(ph n)Ru(NCCH 3)2]+ (9) catalyzes 1,4-regioselective monohydrosilylation of phenanthroline, quinoline, acridine, and 1,3,5-triazine and the 1,2-reduction of isoquinoline. In contrast, 2-substituted phenanthroline, pyrazine, 2-ethylpyridine, 2,6-lutidine, 2,4-lutidine, and pyrimidine are not reduced under these conditions by either of the catalysts studied.

Trisubstituted heterocyclic compounds and their use as fungicides

-

, (2008/06/13)

Compounds of general formula (I): in which:Het represents a five or six membered saturated, partially unsaturated or aromatic ring containing between one and six heteroatoms of the group N, O, S, in which the heterocycle is substituted in an adjacent manner with -P-Q1-T-Q2, -GZ and Y, such that the substituant -GZ is adjacent to both. the other substituants being as defined in the description,process for preparing these compounds,fungicidal compositions comprising these compounds,processes for treating plants by applying these compounds or compositions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 3337-17-5